Aditi Jhaveri
Cited by
Cited by
Stimuli-sensitive nanopreparations for combination cancer therapy
A Jhaveri, P Deshpande, V Torchilin
Journal of controlled release 190, 352-370, 2014
Multifunctional polymeric micelles for delivery of drugs and siRNA
AM Jhaveri, VP Torchilin
Frontiers in pharmacology 5, 77, 2014
Intracellular delivery of nanocarriers and targeting to subcellular organelles
A Jhaveri, V Torchilin
Expert opinion on drug delivery 13 (1), 49-70, 2016
Transferrin-targeted, resveratrol-loaded liposomes for the treatment of glioblastoma
A Jhaveri, P Deshpande, B Pattni, V Torchilin
Journal of Controlled Release 277, 89-101, 2018
The effect of dual ligand-targeted micelles on the delivery and efficacy of poorly soluble drug for cancer therapy
RR Sawant, AM Jhaveri, A Koshkaryev, F Qureshi, VP Torchilin
Journal of drug targeting 21 (7), 630-638, 2013
Targeted transferrin-modified polymeric micelles: enhanced efficacy in vitro and in vivo in ovarian carcinoma
RR Sawant, AM Jhaveri, A Koshkaryev, L Zhu, F Qureshi, VP Torchilin
Molecular pharmaceutics 11 (2), 375-381, 2014
Immunomicelles for advancing personalized therapy
RR Sawant, AM Jhaveri, VP Torchilin
Advanced Drug Delivery Reviews, 2012
Monitoring of magnetic targeting to tumor vasculature through MRI and biodistribution
E Gultepe, FJ Reynoso, A Jhaveri, P Kulkarni, D Nagesha, C Ferris, ...
Nanomedicine 5 (8), 1173-1182, 2010
Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer
P Deshpande, A Jhaveri, B Pattni, S Biswas, V Torchilin
Drug delivery 25 (1), 517-532, 2018
PEG-PE/Clay Composite Carriers for Doxorubicin: Effect of Composite Structure on Release, Cell Interaction and Cytotoxicity.
YGM Hagay Kohay, Can Sarisozen, Rupa Sawant, Aditi Jhaveri, Vladimir P Torchilin
Acta biomaterialia, 2017
Stimuli-Reactive Nanoparticles for Drug Targeting
A Jhaveri, W T, V Torchilin
Controlled Release Systems: Advances in Nanobottles and Active Nanoparticles …, 2015
Targeting energy metabolism of cancer cells: Combined administration of NCL-240 and 2-DG
BS Pattni, A Jhaveri, I Dutta, JD Baleja, A Degterev, V Torchilin
International journal of pharmaceutics 532 (1), 149-156, 2017
Combination Nanopreparations of a Novel Proapoptotic Drug–NCL-240, TRAIL and siRNA
R Riehle, B Pattni, A Jhaveri, A Kulkarni, G Thakur, A Degterev, ...
Pharmaceutical research 33 (7), 1587-1601, 2016
The effect of transferrin-targeted, resveratrol-loaded liposomes on neurosphere cultures of glioblastoma: implications for targeting tumour-initiating cells
A Jhaveri, E Luther, V Torchilin
Journal of drug targeting 27 (5-6), 601-613, 2019
Stimuli-Sensitive Nanopreparations: Overview
A Jhaveri, V Shvets, V Torchilin
Smart Pharmaceutical Nanocarriers, 1, 2015
The Aryl Hydrocarbon Receptor as a regulator of CNS autoimmunity
J Kenison-White, A Jhaveri, S Tezza, D Nowakowska, D Sherr, ...
The Journal of Immunology 202 (1 Supplement), 193.13-193.13, 2019
Micellar nanopreparations for medicine
R Sawant, A Jhaveri
Handbook of Nanobiomedical Research, Vol 1 Materials for Nanomedicine 1, 87-139, 2014
Magnetic nanomedicine and hyperthermia for the treatment of thyroid cancer
A Jhaveri
Tolerogenic nanoliposomes for the treatment of Rheumatoid Arthritis
J Kenison-White, DJ Nowakowska, A Jhaveri, N Khase, S Tezza, D Sherr, ...
The Journal of Immunology 204 (1 Supplement), 237.2-237.2, 2020
Advancing methods for the analysis of glioblastoma cell motion using quantitative time lapse holographic imaging and cellular tomography
E Luther, L Mendes, N Filiczak, A Jhaveri, L Milane, V Torchilin
Imaging, Manipulation, and Analysis of Biomolecules, Cells, and Tissues XVII …, 2019
The system can't perform the operation now. Try again later.
Articles 1–20